CMS is proposing to lower Medicare reimbursement for 340B drugs by almost $5 billion in CY2027. Because the proposal is budget neutral, those $5 billion will be redistributed to all hospitals through higher payments for non-drug outpatient services.
public-inspection.federalregister.gov